Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Medically Attended Outcomes in the United States (U18)

The summary for the Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Medically Attended Outcomes in the United States (U18) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Medically Attended Outcomes in the United States (U18)
	CFDA Number:	93.185
	CFDA Description:	Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects
	Federal Agency Name:	Centers for Disease Control and Prevention
	Category of Funding Activity:	Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-IP-08-001
	Document Type:	Grants Notice
	Funding Instrument Type:	Cooperative Agreement
	Posted Date:	Dec 07, 2007
	Creation Date:	Dec 07, 2007
	Original Closing Date for Applications:	Feb 04, 2008 Applications must be received by 5:00 p.m. on the application deadline date.
	Current Closing Date for Applications:	Information not provided
	Archive Date:	Mar 05, 2008
	Expected Number of Awards:	4
	Estimated Total Program Funding:	$3,000,000
	Federal Grant Award Ceiling:	$1,000,000
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Additional Information on Eligibility: Information not provided
Grant Description: Secretarys Forecast Summary RFA-IP-08-001 CDCs Procurement and Grants Office has published a program announcement entitled, "Annual Estimates of Influenza Vaccine Effectiveness for Preventing Laboratory-Confirmed Medically Attended Outcomes in the United States." Approximately $3,000,000 will be available in fiscal year 2008 to fund approximately four awards. The purpose of the program is to enable several research institutions to conduct annual assessments of the effectiveness of licensed influenza vaccines against laboratory-confirmed medically attended influenza infections diagnosed by viral culture and RT-PCR. For complete program details, please see the full announcement on the CDC website at http://www.cdc.gov/od/pgo/funding/FOAs.htm. The estimated funding date is prior to July 1, 2008.
Link to Full Grant Announcement: RFA-IP-08-001
http://www.cdc.gov/od/pgo/funding/FOAs.htm
Grant Announcement Contact: PGOTIM
Phone 770-488-2700 pgotim@cdc.gov CDC Procurement and Grants Office
Similar Government Grants: • Addressing Immunization Disparities in Minority Populations; • Immunization Strengthening through Measles Control and Related Childhood Morbidity/Mortality Reducti...; • Developing and Disseminating Targeted Immunization Materials; • Integrated Economic, Dynamic Disease, Risk and Decision Analytic Modeling of Global and Domestic Pol...; • Strategies to Increase Health Care Providers Use of Population-Based Immunization Information System...; • Coordination of Activities Between the CDC's National Immunization Program and the State and Ter...; • National Minority Organizations Immunization Projects; • Using Provider Partnerships to Strengthen the Immunization Message; • Coordination of Activities Between the CDC, National Immunization Program and State and Local Immuni...; • Active Surveillance for Pertussis